Oppenheimer Reiterates Outperform on Compass Pathways, Maintains $20 Price Target

Benzinga · 07/07 17:07
Oppenheimer analyst Francois Brisebois reiterates Compass Pathways (NASDAQ:CMPS) with a Outperform and maintains $20 price target.